Quarterly report pursuant to Section 13 or 15(d)

Segment reporting (Details) - Schedule of segment reporting information, by segment

v3.3.1.900
Segment reporting (Details) - Schedule of segment reporting information, by segment - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jan. 31, 2016
Jan. 31, 2015
Jan. 31, 2016
Jan. 31, 2015
Revenues:        
Clinical laboratory services $ 17,523 $ 14,725 $ 34,613 $ 30,547
Product revenues 6,578 7,723 14,265 15,725
Royalty and license fee income 459 644 859 1,644
Total revenues 24,560 23,092 49,737 47,916
Operating expenses:        
Cost of clinical laboratory services 10,535 9,246 20,867 19,376
Cost of product revenues 3,206 3,818 6,817 7,513
Research and development 861 834 1,728 1,625
Selling, general and administrative 11,280 9,670 21,505 19,955
Provision for uncollectible accounts receivable 459 601 1,163 1,142
Legal fee expense 2,411 2,804 4,012 5,270
Legal settlements, net (11,650)   (18,450)  
Operating income (loss) 7,458 (3,881) 12,095 (6,965)
Other income (expense)        
Other 11 (17) 65 2
Foreign exchange gain (loss) (388) (259) (518) (731)
Share-based compensation included in above:        
Share-based compensation 110 105 221 203
Clinical Labs [Member]        
Revenues:        
Clinical laboratory services 17,523 14,725 34,613 30,547
Total revenues 17,523 14,725 34,613 30,547
Operating expenses:        
Cost of clinical laboratory services 10,535 9,246 20,867 19,376
Selling, general and administrative 5,649 5,089 10,935 10,157
Provision for uncollectible accounts receivable 467 658 1,175 1,189
Legal fee expense 57 41 66 131
Legal settlements, net 1,500   1,500  
Total operating expenses 18,208 15,034 34,543 30,853
Operating income (loss) (685) (309) 70 (306)
Other income (expense)        
Interest (23) (12) (42) (39)
Other (1) 4 3 6
Income (loss) before income taxes (709) (317) 31 (339)
Depreciation and amortization included above 411 357 808 714
Share-based compensation included in above:        
Share-based compensation 2 2 3 3
Capital expenditures 354 338 791 589
Life Sciences [Member]        
Revenues:        
Product revenues 6,578 7,723 14,265 15,725
Royalty and license fee income 459 644 859 1,644
Total revenues 7,037 8,367 15,124 17,369
Operating expenses:        
Cost of product revenues 3,206 3,818 6,817 7,513
Research and development 661 635 1,328 1,183
Selling, general and administrative 2,773 2,704 5,832 5,853
Provision for uncollectible accounts receivable (8) (57) (12) (47)
Legal fee expense 5 (53) (17) (51)
Legal settlements, net (13,150)   (19,950)  
Total operating expenses (6,513) 7,047 (6,002) 14,451
Operating income (loss) 13,550 1,320 21,126 2,918
Other income (expense)        
Interest 17 5 31 7
Other   (29) 39 (35)
Foreign exchange gain (loss) (388) (259) (518) (731)
Income (loss) before income taxes 13,179 1,037 20,678 2,159
Depreciation and amortization included above 524 555 1,054 1,113
Share-based compensation included in above:        
Capital expenditures 84 51 152 64
Therapeutics [Member]        
Operating expenses:        
Research and development 200 199 400 442
Total operating expenses 200 199 400 442
Operating income (loss) (200) (199) (400) (442)
Other income (expense)        
Income (loss) before income taxes (200) (199) (400) (442)
Depreciation and amortization included above   1   2
Other Segments [Member]        
Operating expenses:        
Selling, general and administrative 2,858 1,877 4,738 3,945
Legal fee expense 2,349 2,816 3,963 5,190
Total operating expenses 5,207 4,693 8,701 9,135
Operating income (loss) (5,207) (4,693) (8,701) (9,135)
Other income (expense)        
Interest (36) (42) (71) (86)
Other 12 8 23 31
Income (loss) before income taxes (5,231) (4,727) (8,749) (9,190)
Depreciation and amortization included above 17 22 40 44
Consolidated [Member]        
Revenues:        
Clinical laboratory services 17,523 14,725 34,613 30,547
Product revenues 6,578 7,723 14,265 15,725
Royalty and license fee income 459 644 859 1,644
Total revenues 24,560 23,092 49,737 47,916
Operating expenses:        
Cost of clinical laboratory services 10,535 9,246 20,867 19,376
Cost of product revenues 3,206 3,818 6,817 7,513
Research and development 861 834 1,728 1,625
Selling, general and administrative 11,280 9,670 21,505 19,955
Provision for uncollectible accounts receivable 459 601 1,163 1,142
Legal fee expense 2,411 2,804 4,012 5,270
Legal settlements, net (11,650)   (18,450)  
Total operating expenses 17,102 26,973 37,642 54,881
Operating income (loss) 7,458 (3,881) 12,095 (6,965)
Other income (expense)        
Interest (42) (49) (82) (118)
Other 11 (17) 65 2
Foreign exchange gain (loss) (388) (259) (518) (731)
Income (loss) before income taxes 7,039 (4,206) 11,560 (7,812)
Depreciation and amortization included above 952 935 1,902 1,873
Share-based compensation included in above:        
Share-based compensation 2 2 3 3
Capital expenditures 438 389 943 653
Research and Development Expense [Member]        
Share-based compensation included in above:        
Share-based compensation   1   2
Research and Development Expense [Member] | Life Sciences [Member]        
Share-based compensation included in above:        
Share-based compensation   1   2
Research and Development Expense [Member] | Consolidated [Member]        
Share-based compensation included in above:        
Share-based compensation   1   2
Selling, General and Administrative Expenses [Member]        
Share-based compensation included in above:        
Share-based compensation 108 102 218 198
Selling, General and Administrative Expenses [Member] | Clinical Labs [Member]        
Share-based compensation included in above:        
Share-based compensation 9 12 19 21
Selling, General and Administrative Expenses [Member] | Life Sciences [Member]        
Share-based compensation included in above:        
Share-based compensation 5 3 10 3
Selling, General and Administrative Expenses [Member] | Other Segments [Member]        
Share-based compensation included in above:        
Share-based compensation 94 87 189 174
Selling, General and Administrative Expenses [Member] | Consolidated [Member]        
Share-based compensation included in above:        
Share-based compensation 108 102 218 198
Total [Member] | Clinical Labs [Member]        
Share-based compensation included in above:        
Share-based compensation 11 14 22 24
Total [Member] | Life Sciences [Member]        
Share-based compensation included in above:        
Share-based compensation 5 4 10 5
Total [Member] | Other Segments [Member]        
Share-based compensation included in above:        
Share-based compensation 94 87 189 174
Total [Member] | Consolidated [Member]        
Share-based compensation included in above:        
Share-based compensation $ 110 $ 105 $ 221 $ 203